title: Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells.
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: D'Arena
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Vitalba
authors.initials: V
authors.lastname: Ruggieri
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Fiorella
authors.initials: F
authors.lastname: D'Auria
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: La Rocca
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Vittorio
authors.initials: V
authors.lastname: Simeon
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Teodora
authors.initials: T
authors.lastname: Statuto
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Antonella
authors.initials: A
authors.lastname: Caivano
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Donatella
authors.initials: D
authors.lastname: Telesca
authors.affiliation: b CEINGE Institute of Advanced Biotechnologies, University of Naples , Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Del Vecchio
authors.affiliation: a IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture , Potenza , Italy.
authors.forename: Pellegrino
authors.initials: P
authors.lastname: Musto
mesh_terms: D018951:Antigens, CD20 / Q000235:genetics / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002462:Cell Membrane / Q000378:metabolism*; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects; D006801:Humans; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000378:metabolism*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D018951:Antigens, CD20; D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide